Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Holly Clouse"'
Autor:
John P Imredy, Holly Clouse, Armando Lagrutta, Michael P Graziano, Krista M Durney, Wilson Hsieh, Jamie Gearhart, Brian Schriver, Nathan W Bay, Nicole T Feric
Publikováno v:
Circulation Research. 131
MK-8722, a systemic pan-AMPK activator improves glucose homeostasis in animal models of diabetes, but causes cardiac hypertrophy # . Two- and 3-dimensional tissue (2D,3D) constructs of human induced pluripotent stem cell derived cardiomyocytes (CM) (
Publikováno v:
Applied In Vitro Toxicology. 6:144-155
We reported that blockade of Ca2+ channel increased beating rate on human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) when in hiPSC-CM culture media, but decreased beating rate...
Publikováno v:
Toxicological Sciences. 167:573-580
Calcium channel blockers (CCBs), such as diltiazem, nifedipine, and verapamil, cause tachycardia effects on several commercially available human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), when tested in culture media provided b
Publikováno v:
JRSM Cardiovascular Disease, Vol 8 (2019)
Objective We investigated if there is IKs, and if there is repolarization reserve by IKs in human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Design We used a specific KCNQ1/KCNE1 channel blocker, L-000768673, with an IC50 of 9
Autor:
Jennifer B. Pierson, Armando Lagrutta, Holly Clouse, Michael Furniss, Ivan Kopljar, Frederick Sannajust, Ralf Kettenhofen, Haoyu Zeng, Hua Rong Lu, Karel Van Ammel, Fetene Tekle, Ard Teisman, Jin Zhai, Liang Guo, David J. Gallacher
Publikováno v:
Toxicol Sci
The goal of this research consortium including Janssen, MSD, Ncardia, FNCR/LBR, and Health and Environmental Sciences Institute (HESI) was to evaluate the utility of an additional in vitro assay technology to detect potential drug-induced long QT and
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 99:106595
Calcium channel blockers (CCBs), such as diltiazem, nifedipine, and verapamil, cause tachycardia effects on several commercially available human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), when tested in culture media provided b